Anti-CD40-mediated cancer immunotherapy: an update of recent and ongoing clinical trials
出版年份 2014 全文链接
标题
Anti-CD40-mediated cancer immunotherapy: an update of recent and ongoing clinical trials
作者
关键词
-
出版物
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
Volume 36, Issue 2, Pages 96-104
出版商
Informa UK Limited
发表日期
2014-02-21
DOI
10.3109/08923973.2014.890626
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- A Phase I Study of an Agonist CD40 Monoclonal Antibody (CP-870,893) in Combination with Gemcitabine in Patients with Advanced Pancreatic Ductal Adenocarcinoma
- (2013) G. L. Beatty et al. CLINICAL CANCER RESEARCH
- Profile of tivozanib and its potential for the treatment of advanced renal cell carcinoma
- (2013) Lance Cowey Drug Design Development and Therapy
- Phase I study of the CD40 agonist antibody CP-870,893 combined with carboplatin and paclitaxel in patients with advanced solid tumors
- (2013) Robert H. Vonderheide et al. OncoImmunology
- A phase 1 study of lucatumumab, a fully human anti-CD40 antagonist monoclonal antibody administered intravenously to patients with relapsed or refractory multiple myeloma
- (2012) William Bensinger et al. BRITISH JOURNAL OF HAEMATOLOGY
- Soluble CD40 ligand (sCD40L) provides a new delivery system for targeted treatment
- (2012) Rotem Kedar et al. CANCER
- Preclinical Evaluation of TriMix and Antigen mRNA-Based Antitumor Therapy
- (2012) S. Van Lint et al. CANCER RESEARCH
- Agonistic Antibody to CD40 Boosts the Antitumor Activity of Adoptively Transferred T Cells In Vivo
- (2012) Chengwen Liu et al. JOURNAL OF IMMUNOTHERAPY
- Proteasome Inhibition and Combination Therapy for Non-Hodgkin's Lymphoma: From Bench to Bedside
- (2012) A. R. Mato et al. ONCOLOGIST
- Bortezomib Combination Therapy in Multiple Myeloma
- (2012) Prashant Kapoor et al. SEMINARS IN HEMATOLOGY
- Immune modulation with weekly dosing of an agonist CD40 antibody in a phase I study of patients with advanced solid tumors
- (2011) Jens Rüter et al. CANCER BIOLOGY & THERAPY
- Intratumoral interleukin-2/agonist CD40 antibody drives CD4+-independent resolution of treated-tumors and CD4+-dependent systemic and memory responses
- (2011) Connie Jackaman et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Distinct Apoptotic Signaling Characteristics of the Anti-CD40 Monoclonal Antibody Dacetuzumab and Rituximab Produce Enhanced Antitumor Activity in Non-Hodgkin Lymphoma
- (2011) T. S. Lewis et al. CLINICAL CANCER RESEARCH
- Local Activation of CD8 T Cells and Systemic Tumor Eradication without Toxicity via Slow Release and Local Delivery of Agonistic CD40 Antibody
- (2011) M. F. Fransen et al. CLINICAL CANCER RESEARCH
- Costimulatory molecule expression on human uveal melanoma cells: Functional analysis of CD40 and B7-H1
- (2011) Juan Ma et al. EXPERIMENTAL EYE RESEARCH
- Low dose alemtuzumab in patients with fludarabine-refractory chronic lymphocytic leukemia
- (2011) Giuseppe Gritti et al. LEUKEMIA & LYMPHOMA
- CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
- (2011) G. L. Beatty et al. SCIENCE
- A phase I multidose study of dacetuzumab (SGN-40; humanized anti-CD40 monoclonal antibody) in patients with multiple myeloma
- (2010) M. Hussein et al. HAEMATOLOGICA
- Bortezomib Plus CHOP-Rituximab for Previously Untreated Diffuse Large B-Cell Lymphoma and Mantle Cell Lymphoma
- (2010) Jia Ruan et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase I study of dacetuzumab (SGN-40, a humanized anti-CD40 monoclonal antibody) in patients with chronic lymphocytic leukemia
- (2010) Richard R. Furman et al. LEUKEMIA & LYMPHOMA
- Competing feedback loops shape IL-2 signaling between helper and regulatory T lymphocytes in cellular microenvironments
- (2010) D. Busse et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phase I Study of the Humanized Anti-CD40 Monoclonal Antibody Dacetuzumab in Refractory or Recurrent Non-Hodgkin's Lymphoma
- (2009) Ranjana Advani et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunologic and Therapeutic Synergy of IL-27 and IL-2: Enhancement of T Cell Sensitization, Tumor-Specific CTL Reactivity and Complete Regression of Disseminated Neuroblastoma Metastases in the Liver and Bone Marrow
- (2009) R. Salcedo et al. JOURNAL OF IMMUNOLOGY
- Radioimmunotherapy for Stem Cell Transplantation in Non-Hodgkin's Lymphoma: In Pursuit of a Complete Response
- (2009) C. Gisselbrecht et al. ONCOLOGIST
- The antileukemia activity of a human anti-CD40 antagonist antibody, HCD122, on human chronic lymphocytic leukemia cells
- (2008) M. Luqman et al. BLOOD
- Biological Research in the Evolution of Cancer Surgery: A Personal Perspective
- (2008) B. Fisher CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started